Table 1.

Reported results from studies about adverse effects.

AHRQa domains of quality	Adverse effects
Safety	No study-related adverse events [23] No serious adverse advents were found to be related to the mode of the consultation [27] Communication failures [33] Failure to record the content of the communication [33] Failure to consult the patient’s notes prior to engaging in communication [33]
Effectiveness	No difference in re-referrals [27] Reduction in SBPb greater in control group at 12 weeks and similar at 52 weeks [32]
Patient-centeredness	A new perceptual distance between patients and therapists [24] Sense of losing privacy [25] Stigmatization [25] Poor cooperation of the patient [25] Loss of trust [30] Lack of human face-to-face contact [30] Lack of willingness [30] Concerns about promoting the sick role [26] Creates dependence on telemonitoring and professionals [26] Lack of physical contact causes concerns about long-term complications of diabetes [29]
Timeliness	N/Ac
Efficiency	New time-consuming work routines [24] Responsibilities less transparent [24] Mean consultation duration not different [27] Increased triage time [28] Less likely to order urinary tract infection-relevant tests [31] No difference for follow-up visits [31] Overprescribing of antibiotics [31] Less likely to order preventive care [31]
Equitability	N/Ac

^aAHRQ: Agency for Healthcare Research and Quality.

^bSBP: systolic blood pressure.

^cN/A: not applicable, as no adverse effects related to timeliness and equitability were reported in the selected studies.